Sign in to view content

The Impact of Prefilled Syringe Technology on Rates of Endophthalmitis Following Intravitreal Injection of Faricimab

Philip P Storey, MD, MPH

Video
Published 2025

Related

Faricimab in Neovascular Age-Related Macular Degeneration: Week 48 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials
Karl G. Csaky, MD, PhD
Annual Meeting Talks
2021
Complete and early vitrectomy with intravitreal moxifloxacin/dexamethasone for endophthalmitis
Raul Velez-Montoya, MD
On Demand Cases, Courses, and Papers
2019
Intraocular tPA During Vitrectomy for the Management of Severe Bacterial Endophthalmitis
Emmanuel Chang, MD PhD FACS FASRS
Updates from the Field
2025

Category: Inflammatory and Infectious Diseases

See more